![]() | |
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Protein subunit |
Clinical data | |
Trade names | IndoVac |
Routes of administration | Intramuscular |
Part of a series on the |
COVID-19 pandemic |
---|
![]() |
|
![]() |
IndoVac is a recombinant protein subunit COVID-19 vaccine,[1][2] developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas.[1][2] It is the world's first officially halal certified COVID-19 vaccine,[3] but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups.[4][5] The vaccine was officially launched by President Joko Widodo on 13 October 2022.[6]
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search